Standard
Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn's disease : Report and systematic literature review of effectiveness and safety. / Jorgensen, Astrid-Helene Ravn; Holm, Jesper Grønlund; Thomsen, Simon Francis.
I:
Clinical Case Reports, Bind 8, Nr. 12, 2020, s. 2874-2877.
Publikation: Bidrag til tidsskrift › Review › fagfællebedømt
Harvard
Jorgensen, A-HR, Holm, JG
& Thomsen, SF 2020, '
Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn's disease: Report and systematic literature review of effectiveness and safety',
Clinical Case Reports, bind 8, nr. 12, s. 2874-2877.
https://doi.org/10.1002/ccr3.3090APA
Jorgensen, A-H. R., Holm, J. G.
, & Thomsen, S. F. (2020).
Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn's disease: Report and systematic literature review of effectiveness and safety.
Clinical Case Reports,
8(12), 2874-2877.
https://doi.org/10.1002/ccr3.3090Vancouver
Jorgensen A-HR, Holm JG
, Thomsen SF.
Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn's disease: Report and systematic literature review of effectiveness and safety.
Clinical Case Reports. 2020;8(12):2874-2877.
https://doi.org/10.1002/ccr3.3090Author
Jorgensen, Astrid-Helene Ravn ; Holm, Jesper Grønlund ; Thomsen, Simon Francis. / Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn's disease : Report and systematic literature review of effectiveness and safety. I: Clinical Case Reports. 2020 ; Bind 8, Nr. 12. s. 2874-2877.
Bibtex
@article{1116f99b08a84f2e98b32d30a02e514f,
title = "Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn's disease: Report and systematic literature review of effectiveness and safety",
abstract = "Guselkumab appears to be safe and effective in the treatment of patients with HS, who do not respond to adalimumab and other systemic therapies. Guselkumab can be used in patients with comorbid Crohn's disease.",
keywords = "Crohn's disease, guselkumab, Hidradenitis suppurativa, inflammation",
author = "Jorgensen, {Astrid-Helene Ravn} and Holm, {Jesper Gr{\o}nlund} and Thomsen, {Simon Francis}",
year = "2020",
doi = "10.1002/ccr3.3090",
language = "English",
volume = "8",
pages = "2874--2877",
journal = "Clinical Case Reports",
issn = "2050-0904",
publisher = "JohnWiley & Sons Ltd",
number = "12",
}
RIS
TY - JOUR
T1 - Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn's disease
T2 - Report and systematic literature review of effectiveness and safety
AU - Jorgensen, Astrid-Helene Ravn
AU - Holm, Jesper Grønlund
AU - Thomsen, Simon Francis
PY - 2020
Y1 - 2020
N2 - Guselkumab appears to be safe and effective in the treatment of patients with HS, who do not respond to adalimumab and other systemic therapies. Guselkumab can be used in patients with comorbid Crohn's disease.
AB - Guselkumab appears to be safe and effective in the treatment of patients with HS, who do not respond to adalimumab and other systemic therapies. Guselkumab can be used in patients with comorbid Crohn's disease.
KW - Crohn's disease
KW - guselkumab
KW - Hidradenitis suppurativa
KW - inflammation
U2 - 10.1002/ccr3.3090
DO - 10.1002/ccr3.3090
M3 - Review
C2 - 33363841
VL - 8
SP - 2874
EP - 2877
JO - Clinical Case Reports
JF - Clinical Case Reports
SN - 2050-0904
IS - 12
ER -
